Completed OBSERVATIONAL NCT01162330

The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred for Further Hearing Assessment (BEST)

The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred for Further Hearing Assessment After Their Neonatal Screen (BEST)

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust

Conditions Cytomegalovirus Hearing Loss

Interventions Screening urine and saliva tests for congenital Cytomegalovirus

Updated 6 times since 2017 Last updated: Oct 7, 2015 Started: Aug 31, 2010 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cytomegalovirus and Hearing Loss, this trial is completed. The trial is conducted by Newcastle-upon-Tyne Hospitals NHS Trust and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Newcastle-upon-Tyne Hospitals NHS Trust

Data source: Newcastle-upon-Tyne Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newcastle upon Tyne, United Kingdom